Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement. While ...

The procedure that delivers a bioprosthetic device through flexible tube ... Transcatheter aortic valve implantation (TAVI) and transcatheter aortic valve replacement (TAVR) refer to the exact same ...

CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year incidence of bioprosthetic valve dysfunction than surgery. Valve dysfunction was also ...

"The decision between a bioprosthetic and a mechanical ... many patients and the recent trend of bioprosthetic transcatheter ...

In contrast, bioprosthetic valves can be expected ... highlighted the implications regarding surgery versus transcatheter aortic valve replacement (TAVR). "Despite clear guidelines to the contrary ...

Patients randomized to TAVR in this study received the Medtronic Evolut R, PRO or CoreValve bioprosthesis ... year Outcomes After Transcatheter Or Surgical Aortic Valve Replacement In Low-risk ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary Resilia tissue.

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system exceeded safety and performance goals, according to results of the ALIGN-AR ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...